Treatment of refractory acute leukemia with high-dose cytosine arabinoside. 1987

M C Liu, and Y C Chen, and W Tsay, and M C Shen, and C H Wang, and C H Liu

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005260 Female Females
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M C Liu, and Y C Chen, and W Tsay, and M C Shen, and C H Wang, and C H Liu
January 1985, Neoplasma,
M C Liu, and Y C Chen, and W Tsay, and M C Shen, and C H Wang, and C H Liu
October 1979, Cancer,
M C Liu, and Y C Chen, and W Tsay, and M C Shen, and C H Wang, and C H Liu
December 1984, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M C Liu, and Y C Chen, and W Tsay, and M C Shen, and C H Wang, and C H Liu
July 1982, British journal of haematology,
M C Liu, and Y C Chen, and W Tsay, and M C Shen, and C H Wang, and C H Liu
August 1983, Blood,
M C Liu, and Y C Chen, and W Tsay, and M C Shen, and C H Wang, and C H Liu
September 1984, Blood,
M C Liu, and Y C Chen, and W Tsay, and M C Shen, and C H Wang, and C H Liu
January 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
M C Liu, and Y C Chen, and W Tsay, and M C Shen, and C H Wang, and C H Liu
August 1988, Cancer,
M C Liu, and Y C Chen, and W Tsay, and M C Shen, and C H Wang, and C H Liu
January 1982, Medical and pediatric oncology,
M C Liu, and Y C Chen, and W Tsay, and M C Shen, and C H Wang, and C H Liu
August 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!